ZA956797B - Method for preparing influenza virus, antigens obtained and the applications. - Google Patents
Method for preparing influenza virus, antigens obtained and the applications.Info
- Publication number
- ZA956797B ZA956797B ZA9506797A ZA956797A ZA956797B ZA 956797 B ZA956797 B ZA 956797B ZA 9506797 A ZA9506797 A ZA 9506797A ZA 956797 A ZA956797 A ZA 956797A ZA 956797 B ZA956797 B ZA 956797B
- Authority
- ZA
- South Africa
- Prior art keywords
- applications
- influenza virus
- antigens obtained
- preparing influenza
- preparing
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16163—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9410039A FR2723740B1 (fr) | 1994-08-16 | 1994-08-16 | Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA956797B true ZA956797B (en) | 1997-02-17 |
Family
ID=9466323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9506797A ZA956797B (en) | 1994-08-16 | 1995-08-15 | Method for preparing influenza virus, antigens obtained and the applications. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6048537A (es) |
EP (1) | EP0776362A1 (es) |
JP (1) | JPH10504033A (es) |
AU (1) | AU701024B2 (es) |
CA (1) | CA2197683C (es) |
FR (1) | FR2723740B1 (es) |
MX (1) | MX9701183A (es) |
NZ (1) | NZ288254A (es) |
WO (1) | WO1996005294A1 (es) |
ZA (1) | ZA956797B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
GB9924351D0 (en) | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
EP1103610A1 (en) * | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production of vaccines from immortalised mammalian cell lines |
US6951752B2 (en) | 2001-12-10 | 2005-10-04 | Bexter Healthcare S.A. | Method for large scale production of virus antigen |
KR100473070B1 (ko) * | 2002-08-31 | 2005-03-10 | 박승국 | 시각적 유도장치를 이용한 외국어 학습 및 교습 시스템 |
CA2503774C (en) * | 2003-06-20 | 2007-09-25 | Microbix Biosystems Inc. | Improvements in virus production |
MXPA06013411A (es) * | 2004-05-20 | 2007-07-04 | Id Biomedical Corp | Procedimiento para la produccion de una vacuna contra la influenza. |
US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
JP2009514844A (ja) * | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | スプリットインフルエンザワクチン用のアジュバントとしての遊離水相界面活性剤を含むエマルション |
CA2642485A1 (en) * | 2006-02-23 | 2007-08-30 | Leonard Moran | Improved methods of producing avian eggs and birds of specified germ-free status |
AU2008279584A1 (en) * | 2007-04-27 | 2009-01-29 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
BRPI0811533A2 (pt) * | 2007-05-04 | 2014-10-14 | Baxter Int | Método para a produção de um vírus |
EP2192917B1 (en) * | 2007-08-28 | 2014-01-29 | Baxter International Inc. | Method for producing viral vaccines |
TW200936758A (en) * | 2007-11-02 | 2009-09-01 | Intervet Int Bv | Orthomyxoviridae propagation |
TWI444384B (zh) * | 2008-02-20 | 2014-07-11 | Gilead Sciences Inc | 核苷酸類似物及其在治療惡性腫瘤上的用途 |
KR101695800B1 (ko) | 2008-03-05 | 2017-02-22 | 사노피 파스퇴르 | 항원보강제 함유 백신 조성물의 안정화 방법 |
JP5518041B2 (ja) | 2008-03-18 | 2014-06-11 | ノバルティス アーゲー | インフルエンザウイルスワクチン抗原の調製における改良 |
EP2393922A1 (en) | 2009-02-06 | 2011-12-14 | GlaxoSmithKline Biologicals S.A. | Purification of virus or viral antigens by density gradient ultracentrifugation |
JP5823379B2 (ja) * | 2009-05-29 | 2015-11-25 | ノバルティス アーゲー | インフルエンザウイルスヘマグルチニンについてのアッセイ |
DK2475384T3 (en) | 2009-09-10 | 2016-10-24 | Merial Inc | NEW VACCINE FORMULATIONS COMPREHENSIVE saponin-CONTAINING ADJUVANTS |
JP2013523175A (ja) | 2010-04-14 | 2013-06-17 | イーエムディー・ミリポア・コーポレーション | 高力価、高純度のウイルスストックの作製方法及びその使用方法 |
US10166188B2 (en) | 2011-08-12 | 2019-01-01 | Merial, Inc. | Method for vacuum-assisted preservation of biologics including vaccines |
FR3025107B1 (fr) | 2014-08-29 | 2018-10-05 | Calixar | Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations |
TWI745278B (zh) | 2014-10-10 | 2021-11-11 | 以色列商艾畢克生物實驗有限公司 | 發泡性降低之疫苗組合物 |
WO2017218819A1 (en) | 2016-06-17 | 2017-12-21 | Merial, Inc. | Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4064232A (en) * | 1974-01-14 | 1977-12-20 | Sandoz Ltd. | Process for isolating the immunogenic components of influenza viruses |
US4000257A (en) * | 1975-12-22 | 1976-12-28 | American Cyanamid Company | Process for the purification of influenza virus vaccine |
US4057626A (en) * | 1976-10-08 | 1977-11-08 | Richardson-Merrell Inc. | Process for detoxifying influenza B virus |
FR2475572A1 (fr) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications |
DE3014189A1 (de) * | 1980-04-14 | 1981-10-15 | Europäisches Laboratorium für Molekularbiologie (EMBL), 6900 Heidelberg | Verfahren zur herstellung eines immunogenen membranproteinaggregats von influenza-, parainfluenza- und rhabdo-viren |
FR2483779A1 (fr) * | 1980-06-05 | 1981-12-11 | Synthelabo | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
US4327182A (en) * | 1981-01-22 | 1982-04-27 | Connaught Laboratories Incorporated | Purification of influenza sub-unit vaccine |
FR2671974A1 (fr) * | 1991-01-24 | 1992-07-31 | Pasteur Merieux Serums Vacc | Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal. |
-
1994
- 1994-08-16 FR FR9410039A patent/FR2723740B1/fr not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/793,373 patent/US6048537A/en not_active Expired - Lifetime
- 1995-06-06 NZ NZ288254A patent/NZ288254A/xx not_active IP Right Cessation
- 1995-06-06 JP JP8507053A patent/JPH10504033A/ja active Pending
- 1995-06-06 CA CA002197683A patent/CA2197683C/en not_active Expired - Lifetime
- 1995-06-06 WO PCT/FR1995/000727 patent/WO1996005294A1/fr not_active Application Discontinuation
- 1995-06-06 EP EP95922563A patent/EP0776362A1/fr not_active Withdrawn
- 1995-06-06 MX MX9701183A patent/MX9701183A/es unknown
- 1995-06-06 AU AU27412/95A patent/AU701024B2/en not_active Expired
- 1995-08-15 ZA ZA9506797A patent/ZA956797B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU701024B2 (en) | 1999-01-21 |
FR2723740A1 (fr) | 1996-02-23 |
AU2741295A (en) | 1996-03-07 |
CA2197683C (en) | 2008-12-30 |
FR2723740B1 (fr) | 1996-11-08 |
CA2197683A1 (en) | 1996-02-22 |
JPH10504033A (ja) | 1998-04-14 |
WO1996005294A1 (fr) | 1996-02-22 |
US6048537A (en) | 2000-04-11 |
NZ288254A (en) | 1999-01-28 |
EP0776362A1 (fr) | 1997-06-04 |
MX9701183A (es) | 1997-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA956797B (en) | Method for preparing influenza virus, antigens obtained and the applications. | |
HK1002055A1 (en) | Polyepitope vaccines. | |
EP0665590A3 (en) | Micromechanical element, manufacturing method therefor and devices with this element. | |
EP0632099A3 (en) | Organopolysiloxan and method for preparing it. | |
ZA964710B (en) | Novel compounds, the preparation and use thereof. | |
EP0941981A4 (en) | CYCLOPENTENONES, THEIR PREPARATION PROCESS AND THEIR USE | |
AU7198291A (en) | Human monoclonal antibodies against rabies viruses, the production and the use thereof | |
EP0679677A3 (en) | Process for producing an organically modified, thermosetting siloxane resin and the resin thus produced. | |
EP0661331A3 (en) | Polymer containing silicon, process for its preparation and monomer. | |
EP0599159A3 (de) | a-L-Rhamnosidase zur Gewinnung von Rhamnose, ein Verfahren zur Herstellung und ihre Verwendung. | |
EP0615964A3 (en) | Aluminum nitride ceramic and process for producing the same. | |
AU6926496A (en) | New cyclic guanidines, process for preparing the same and medicaments | |
AU5289193A (en) | New influenza virus peptides, diagnostics and vaccines | |
AU689345B2 (en) | Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same | |
EP0622369A3 (de) | 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung. | |
EP0675137A3 (en) | Cyclic structured glucans and process for their preparation. | |
ZA969402B (en) | Novel oligopeptides, the preparation and use thereof. | |
AU2631895A (en) | Fixing device, and method for the manufacture thereof | |
ITRM950335A0 (it) | Procedimento per regoalre le frequenze di riferimento in un sistema dicomunicazioni. | |
EP0669361A3 (en) | Process for the preparation of polyheterosiloxanes. | |
AU4115796A (en) | Iminooxymethylene anilides, process for preparing the same and their use | |
EP0589051A4 (en) | COMPOSITION FOR HIGH PRESSURE MOLDING PASTE, PASTE FOR HIGH PRESSURE MOLDING AND METHOD FOR PREPARING THE SAME. | |
HUP9700747A1 (en) | Novel retinoids, pharmaceutical compns. contg. them and process for preparing the said compds. | |
HUT77004A (hu) | Antiaritmiás szerekként felhasználható nitro-benzamidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
EP0675171A3 (de) | Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung. |